CELLOMET provides services for the pharmaceutical industry and the cosmetics industry, in Europe, the United States and Asia. CELLOMET also works with French academic laboratories.
Composed of experts in metabolism and biochemistry, CELLOMET relies on a proprietary technological platform specialized in the analysis of metabolic pathways (Seahorse, Oroboros, Biolog, etc.) and their remodeling (proteomics, metabolomics, bioinformatics analysis) to understand the mechanism of action of drugs or active ingredients, but also the effect of genetic modulations. The mitotoxicity of the compounds is also evaluated as well as the biomarkers of mitochondrial modulation in clinical trials.
CELLOMET helps its customers to develop and then carry out their R&D projects in the field of bioenergetics, mitochondrial physiology, modulation of the respiratory chain, oxidative stress and metabolic reprogramming. CELLOMET's skills make it possible to propose an experimental design adapted to bioenergetic analysis as well as to interpret the results of mitochondrial genetics, metabo-proteomics or REDOX signaling.
Rodrigue Rossignol, founder of the cell and Nivea Dias Amoedo, operational director, are accompanied by three other people to carry out these projects. CELLOMET also benefits from the financial management service and the legal department of ADERA.
CELLOMET is accredited Research Tax Credit Expert allowing its customers to benefit from a tax credit on the services provided.